Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Depreciation & Amortization (CF) (2016 - 2025)

Northwest Biotherapeutics' Depreciation & Amortization (CF) history spans 16 years, with the latest figure at $728000.0 for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $728000.0 for Q4 2025, up 66.59% from a year ago — trailing twelve months through Dec 2025 was $2.1 million (up 18.35% YoY), and the annual figure for FY2025 was $2.1 million, up 18.35%.
  • Depreciation & Amortization (CF) for Q4 2025 was $728000.0 at Northwest Biotherapeutics, up from $451000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $728000.0 in Q4 2025 to a low of $68000.0 in Q1 2021.
  • The 5-year median for Depreciation & Amortization (CF) is $420000.0 (2023), against an average of $345450.0.
  • The sharpest move saw Depreciation & Amortization (CF) soared 3750.0% in 2021, then plummeted 33.21% in 2023.
  • Year by year, Depreciation & Amortization (CF) stood at $84000.0 in 2021, then soared by 278.57% to $318000.0 in 2022, then surged by 33.33% to $424000.0 in 2023, then rose by 3.07% to $437000.0 in 2024, then skyrocketed by 66.59% to $728000.0 in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $728000.0, $451000.0, and $451000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.